X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3991) 3991
Publication (365) 365
Book Review (34) 34
Book Chapter (10) 10
Conference Proceeding (9) 9
Dissertation (3) 3
Magazine Article (2) 2
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3151) 3151
camptothecin - analogs & derivatives (2843) 2843
index medicus (2035) 2035
female (1856) 1856
oncology (1835) 1835
male (1801) 1801
camptothecin - administration & dosage (1761) 1761
middle aged (1376) 1376
irinotecan (1335) 1335
aged (1309) 1309
cancer (1306) 1306
chemotherapy (1180) 1180
camptothecin (1154) 1154
adult (1139) 1139
animals (1139) 1139
antineoplastic combined chemotherapy protocols - therapeutic use (1100) 1100
pharmacology & pharmacy (1006) 1006
camptothecin - pharmacology (784) 784
camptothecin - therapeutic use (757) 757
camptothecin - adverse effects (716) 716
colorectal neoplasms - drug therapy (703) 703
mice (690) 690
treatment outcome (681) 681
camptothecin - pharmacokinetics (665) 665
colorectal cancer (592) 592
fluorouracil - administration & dosage (522) 522
antineoplastic combined chemotherapy protocols - adverse effects (518) 518
cell line, tumor (498) 498
cpt-11 (476) 476
colorectal neoplasms - pathology (472) 472
care and treatment (470) 470
pharmacokinetics (435) 435
medicine & public health (434) 434
antineoplastic agents, phytogenic - administration & dosage (424) 424
analysis (406) 406
research (390) 390
antineoplastic combined chemotherapy protocols - administration & dosage (388) 388
metastasis (383) 383
neoplasms - drug therapy (376) 376
antineoplastic agents (373) 373
fluorouracil (372) 372
tumors (371) 371
dose-response relationship, drug (366) 366
camptothecin - chemistry (365) 365
antimitotic agents (348) 348
leucovorin - administration & dosage (341) 341
drug administration schedule (336) 336
organoplatinum compounds - administration & dosage (336) 336
antineoplastic agents, phytogenic - pharmacokinetics (332) 332
drugs (328) 328
apoptosis (327) 327
topotecan (322) 322
oxaliplatin (316) 316
therapy (316) 316
aged, 80 and over (314) 314
antineoplastic agents - pharmacology (313) 313
antineoplastic agents - therapeutic use (313) 313
bevacizumab (312) 312
disease-free survival (309) 309
pharmacology/toxicology (307) 307
antineoplastic agents - administration & dosage (300) 300
camptothecin - blood (299) 299
toxicity (298) 298
drug delivery systems (296) 296
leucovorin (288) 288
drug therapy (287) 287
antineoplastic agents, phytogenic - therapeutic use (279) 279
rats (277) 277
cancer research (274) 274
lung neoplasms - drug therapy (273) 273
trial (267) 267
phase-i (262) 262
antineoplastic agents, phytogenic - pharmacology (261) 261
nanoparticles (261) 261
cisplatin (260) 260
sn-38 (258) 258
apoptosis - drug effects (254) 254
antitumor-activity (252) 252
survival rate (251) 251
topoisomerase i inhibitors (248) 248
combination (244) 244
neoplasm metastasis (241) 241
phase-ii (241) 241
adenocarcinoma - drug therapy (239) 239
neoplasm staging (234) 234
5-fluorouracil (230) 230
clinical trials (230) 230
article (228) 228
deoxycytidine - analogs & derivatives (224) 224
mice, nude (223) 223
liver neoplasms - secondary (221) 221
topoisomerase-i (221) 221
survival (220) 220
fluorouracil - therapeutic use (216) 216
antineoplastic agents, phytogenic - adverse effects (215) 215
solid tumors (213) 213
infusions, intravenous (211) 211
surgery (208) 208
prognosis (206) 206
biochemistry & molecular biology (205) 205
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3901) 3901
Japanese (68) 68
Chinese (19) 19
French (9) 9
German (5) 5
Russian (4) 4
Czech (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Drug Targeting, ISSN 1061-186X, 09/2015, Volume 23, Issue 7-8, pp. 736 - 749
Journal Article
ACS Applied Materials and Interfaces, ISSN 1944-8244, 2019, Volume 11, Issue 25, pp. 22141 - 22151
Recently, cell membrane-derived nanoparticles, particularly of RBCs, have been explored for delivery of hydrophilic solutes of varied size and complexities. So... 
camptothecin | theranostic | lung carcinoma | CM-DiI | RBC-derived nanovesicles | COMPLEMENT | ACTIVATION | MATERIALS SCIENCE, MULTIDISCIPLINARY | DOXORUBICIN | ELIMINATION | NANOSCIENCE & NANOTECHNOLOGY | BIODISTRIBUTION | IN-VITRO | POLYMERIC NANOPARTICLES | NANOERYTHROSOMES | EXOSOMES | PEGYLATED LIPOSOMES
Journal Article
Journal Article
Biopharmaceutics & Drug Disposition, ISSN 0142-2782, 09/2019, Volume 40, Issue 8, pp. 265 - 275
AR‐67 is a lipophilic camptothecin analog currently under clinical investigation using a Cremophor EL based formulation. However, as potential toxicity... 
SBE‐β‐CD | Cremophor EL | camptothecin | pharmacokinetic modeling | Analysis | Cyclodextrins | Models | Formulations | Lipophilic | Camptothecin | Parameter estimation | Cyclodextrin | Intravenous administration | Toxicity | Linearity | Oral administration | Pharmacology
Journal Article
Investigational New Drugs, ISSN 0167-6997, 6/2014, Volume 32, Issue 3, pp. 473 - 480
Background Efatutazone, a novel oral highly-selective peroxisome proliferator-activated receptor gamma (PPARγ) agonist, has demonstrated some inhibitory... 
Peroxisome proliferator-activated receptor gamma | Efatutazone | Medicine & Public Health | Colorectal cancer | Oncology | Pharmacology/Toxicology | FOLFIRI | LIGANDS | ONCOLOGY | ADIPONECTIN | PHARMACOLOGY & PHARMACY | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - administration & dosage | Thiazolidinediones - administration & dosage | Thiazolidinediones - pharmacokinetics | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Fluorouracil - blood | Colorectal Neoplasms - drug therapy | Camptothecin - blood | Adult | Camptothecin - administration & dosage | Female | Antineoplastic Agents - pharmacokinetics | Camptothecin - analogs & derivatives | Camptothecin - pharmacokinetics | Leucovorin - blood | Camptothecin - adverse effects | Administration, Oral | Colorectal Neoplasms - blood | Treatment Outcome | Biomarkers - blood | Thiazolidinediones - adverse effects | Leucovorin - pharmacokinetics | Adiponectin - blood | PPAR gamma - agonists | Antineoplastic Agents - blood | Aged | Fluorouracil - pharmacokinetics | Thiazolidinediones - blood | Antimitotic agents | Complications and side effects | Dosage and administration | Research | Drug therapy | Pharmacokinetics | Antineoplastic agents | Statistical analysis | Research & development--R&D | Toxicity | Cancer therapies | Patients | Drug dosages | Pharmaceuticals | Phase I Studies
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 2015, Volume 17, Issue 8, pp. 1148 - 1156
Journal Article
by Shao, N and Cai, Q
Clinical and Translational Oncology, ISSN 1699-048X, 10/2015, Volume 17, Issue 10, pp. 772 - 778
Compared to pure small cell lung cancer (SCLC), combined small cell lung cancer (C-SCLC) has its own characteristics. High neutrophil to lymphocyte ratio (NLR)... 
Combined small cell lung cancer | Oncology | Prognosis | Medicine & Public Health | Tumor-related inflammation | Neutrophil to lymphocyte ratio | C-REACTIVE PROTEIN | SURVIVAL | SCLC | MARKER | CHEMOTHERAPY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | GASTRIC-CANCER | MIXED SMALL-CELL | SUPERIOR | Carcinoma, Squamous Cell - blood | Adenocarcinoma - pathology | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Pneumonectomy | Small Cell Lung Carcinoma - blood | Neoplasms, Complex and Mixed - therapy | Neoplasm Recurrence, Local - pathology | Lymphocytes | Camptothecin - administration & dosage | Female | Leukocyte Count | Retrospective Studies | Neoplasm Recurrence, Local - blood | Neoplasms, Complex and Mixed - blood | Camptothecin - analogs & derivatives | Carcinoma, Large Cell - blood | Adenocarcinoma - blood | Neoplasm Recurrence, Local - therapy | Blood Platelets | Neutrophils | Carcinoma, Squamous Cell - therapy | Lung Neoplasms - therapy | Radiotherapy | Disease-Free Survival | Small Cell Lung Carcinoma - pathology | Platelet Count | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Complex and Mixed - pathology | Lymphocyte Count | Aged | Lung Neoplasms - blood | Small Cell Lung Carcinoma - therapy | Platinum Compounds - administration & dosage | Neoplasm Staging | Carcinoma, Large Cell - therapy | Cohort Studies | Lung cancer, Small cell | Analysis
Journal Article
Journal Article